Cargando…
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review
The term severe mental illness (SMI) encompasses those psychiatric disorders exerting the highest clinical burden and socio-economic impact on the affected individuals and their communities. Pharmacogenomic (PGx) approaches hold great promise in personalizing treatment selection and clinical outcome...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003720/ https://www.ncbi.nlm.nih.gov/pubmed/36902205 http://dx.doi.org/10.3390/ijms24054776 |